DexCare Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
173
- Latest Deal Type
-
Series C
- Latest Deal Amount
-
$75M
- Investors
-
8
DexCare General Information
Description
Developer of access optimization platform designed to intelligently orchestrate health system capacity and digital demand across all lines of business. The company's platform helps patients to get the right care setting, enabling healthcare institutions to generate new patients, increase revenue, better satisfaction, and substantial cost savings, patients get the care they need faster, easier, and with better results.
Contact Information
Website
www.dexcare.comCorporate Office
- 2324 Eastlake Avenue East
- Suite 500
- Seattle, WA 98102
- United States
Corporate Office
- 2324 Eastlake Avenue East
- Suite 500
- Seattle, WA 98102
- United States
DexCare Timeline
DexCare Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Later Stage VC (Series C) | 21-Jun-2023 | $75M | Completed | Generating Revenue | ||
| 2. Later Stage VC (Series B) | 13-Jan-2022 | Completed | Generating Revenue | |||
| 1. Later Stage VC (Series A) | 10-Mar-2021 | $20M | $20M | Completed | Generating Revenue |
DexCare Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C-1 | ||||||||
| Series C | ||||||||
| Series B | 34,040,231 | $0.000100 | $1.47 | $1.47 | 1x | $1.47 | 18.42% | |
| Series A | 37,815,348 | $0.000100 | $0.56 | $0.56 | 1x | $0.56 | 20.46% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
DexCare Comparisons
Industry
Financing
Details
DexCare Competitors (64)
One of DexCare’s 64 competitors is hc1 Insights, a Venture Capital-Backed company based in Indianapolis, IN.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| hc1 Insights | Venture Capital-Backed | Indianapolis, IN | ||||
| Lumeris | Venture Capital-Backed | Maryland Heights, MO | ||||
| Loopback Analytics | Private Equity-Backed | Dallas, TX | ||||
| Hindsait | Venture Capital-Backed | Hackensack, NJ | ||||
| Innovaccer | Venture Capital-Backed | San Francisco, CA |
DexCare Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
DexCare Patents
DexCare Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-12243638-B1 | Generating service offerings based on associated content and historical data | Active | 25-Mar-2024 | ||
| US-20250103405-A1 | Entity relationships and versioning | Pending | 22-Sep-2023 | ||
| US-11641385-B1 | Verifying performance and operation of live services | Active | 10-Jun-2022 | ||
| US-11930060-B2 | Verifying performance and operation of live services | Active | 10-Jun-2022 | ||
| US-20230403314-A1 | Verifying performance and operation of live services | Active | 10-Jun-2022 | H04L65/611 |
DexCare Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
DexCare Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| ICONIQ Growth | Venture Capital | Minority | ||
| Mass General Brigham Ventures | Venture Capital | Minority | ||
| Transformation Capital | Growth/Expansion | Minority | ||
| Allumia Ventures | Venture Capital | Minority | ||
| Define Ventures | Venture Capital | Minority |
DexCare Acquisitions (1)
DexCare’s most recent deal was a Merger/Acquisition with WompMobile. The deal was made on 13-Oct-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| WompMobile | 13-Oct-2022 | Merger/Acquisition | Business/Productivity Software |
DexCare FAQs
-
When was DexCare founded?
DexCare was founded in 2021.
-
Where is DexCare headquartered?
DexCare is headquartered in Seattle, WA.
-
What is the size of DexCare?
DexCare has 173 total employees.
-
What industry is DexCare in?
DexCare’s primary industry is Enterprise Systems (Healthcare).
-
Is DexCare a private or public company?
DexCare is a Private company.
-
What is the current valuation of DexCare?
The current valuation of DexCare is .
-
What is DexCare’s current revenue?
The current revenue for DexCare is .
-
How much funding has DexCare raised over time?
DexCare has raised $145M.
-
Who are DexCare’s investors?
ICONIQ Growth, Mass General Brigham Ventures, Transformation Capital, Allumia Ventures, and Define Ventures are 5 of 8 investors who have invested in DexCare.
-
Who are DexCare’s competitors?
hc1 Insights, Lumeris, Loopback Analytics, Hindsait, and Innovaccer are some of the 64 competitors of DexCare.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
